Evidence map›Paper›PMID 39509031›Full record

ArticleDermatology and therapy2024

Evaluation of the Biological Effect of a Nicotinamide-Containing Broad-Spectrum Sunscreen on Photodamaged Skin.

Teresa Torres-Moral, Gemma Tell-Martí, Jaume Bague, Pau Rosés-Gibert, Neus Calbet-Llopart, Judit Mateu, Javiera Pérez-Anker, Míriam Potrony, Beatriz Alejo, Pablo Iglesias and 16 more

Registry-linked trialAbstract read
In one paragraph

Article in Dermatology and therapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07286318 (A Randomized Controlled Trial of Topical 5% Niacinamide for Skin Cancer Prevention in Transplant Recipients), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07286318 early_phase1recruitingnot on this mapstarted 2026, after this paper: background citation

A Randomized Controlled Trial of Topical 5% Niacinamide for Skin Cancer Prevention in Transplant Recipients

TypeinterventionalSponsorMarissa LoblRan2026 to 2027Enrolled20ConditionsSkin Cancer, Cutaneous Squamous Cell Carcinoma (CSCC), Actinic Keratosis (AK), Organ Transplant RecipientArmsTopical niacinamide 5% cream, Sunscreen
3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Teresa Torres-MoralCentro de Investigación Biomédica en Red de Enfermedades Raras, CIBERER, Instituto de Salud Carlos III, Barcelona, Spain.
Gemma Tell-MartíCentro de Investigación Biomédica en Red de Enfermedades Raras, CIBERER, Instituto de Salud Carlos III, Barcelona, Spain.
Jaume BagueDermatology Department, Hospital Clínic de Barcelona, IDIBAPS, Villarroel 170, 08036, Barcelona, Spain.
Pau Rosés-GibertDermatology Department, Hospital Clínic de Barcelona, IDIBAPS, Villarroel 170, 08036, Barcelona, Spain.
Neus Calbet-LlopartCentro de Investigación Biomédica en Red de Enfermedades Raras, CIBERER, Instituto de Salud Carlos III, Barcelona, Spain.
Judit MateuDermatology Department, Hospital Clínic de Barcelona, IDIBAPS, Villarroel 170, 08036, Barcelona, Spain.
Javiera Pérez-AnkerDermatology Department, Hospital Clínic de Barcelona, IDIBAPS, Villarroel 170, 08036, Barcelona, Spain.
Míriam PotronyCentro de Investigación Biomédica en Red de Enfermedades Raras, CIBERER, Instituto de Salud Carlos III, Barcelona, Spain.
Beatriz AlejoDermatology Department, Hospital Clínic de Barcelona, IDIBAPS, Villarroel 170, 08036, Barcelona, Spain.
Pablo IglesiasDermatology Department, Hospital Clínic de Barcelona, IDIBAPS, Villarroel 170, 08036, Barcelona, Spain.
Natalia EspinosaBiochemistry and Molecular Genetics Department, Hospital Clínic de Barcelona, IDIBAPS, Barcelona, Spain.
Carmen Orte CanoDermatology Department, Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium.
Elisa CinottiDermatology Unit, Department of Medical, Surgical and Neurological Sciences, University of Siena, Siena, Italy.
Véronique Del MarmolDermatology Department, Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium.
Margot FontaineDermatology Department, Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium.
Makiko MiyamotoDermatology Department, Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium.
Jilliana MonnierDermatology and Skin Cancers Department, La Timone Hospital, AP-HM, Aix-Marseille University, Marseille, France.
Jean Luc PerrotMelanoma Unit, University Hospital of Saint-Etienne, Saint-Etienne, France.
Pietro RubegniDermatology Unit, Department of Medical, Surgical and Neurological Sciences, University of Siena, Siena, Italy.
Linda TognettiDermatology Unit, Department of Medical, Surgical and Neurological Sciences, University of Siena, Siena, Italy.
Mariano SuppaDermatology Department, Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium.
Anne Laure Demessant-FlavignyLaboratoire Dermatologique, La Roche-Posay, Levallois-Perret, France.
Caroline Le Floc'hLaboratoire Dermatologique, La Roche-Posay, Levallois-Perret, France.
Leonor PrietoScientific Direction, Laboratoire Dermatologique La Roche-Posay, L'Oréal Cosmética Activa, Madrid, Spain.
Josep MalvehyCentro de Investigación Biomédica en Red de Enfermedades Raras, CIBERER, Instituto de Salud Carlos III, Barcelona, Spain.
Susana PuigCentro de Investigación Biomédica en Red de Enfermedades Raras, CIBERER, Instituto de Salud Carlos III, Barcelona, Spain. spuig@clinic.cat.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionUVA-UVB increases skin matrix metalloproteinases and breaks down extracellular proteins and fibrillar type 1 collagen, leading to photodamage. Topical application of nicotinamide prevents UV-induced immunosuppression. Several studies have demonstrated the importance of protection against UV. This study aims to determine the biological effect of a high broad-spectrum UVB-UVA sunscreen containing nicotinamide and panthenol (SSNP) on photodamaged skin using linear confocal optical coherence tomography (LC-OCT), immunohistochemistry, and RNA profiling.

methodsTwo areas of severely photodamaged forearm skin (L01 and L02) and one less sun-damaged (naturally protected) area on the inner part of the forearm (L03) were identified in 14 subjects. These areas were imaged using LC-OCT and L01 and L03 were biopsied at baseline. After 4 weeks of treatment with SSNP, L02 was reimaged using LC-OCT, and biopsied. Histology, immunostaining with p21, p53, PCNA, and CPD, and RNA sequencing were performed in all samples.

resultsLC-OCT analysis showed that epidermis thickness and the number of keratinocytes is higher in the sun-exposed areas than in the non-exposed areas. Comparing before and after treatment, even though there is a trend towards normalization, the differences were not statistically significant. The expression of p21, PCNA, p53, and CPD increased in severely photodamaged skin compared to less-damaged skin. When comparing before and after treatment, only p21 showed a trend to decrease expression. RNA sequencing analysis identified 1552 significant genes correlating with the progression from non-visibly photodamaged skin to post-treatment and pre-treatment samples; in the analysis comparing pre- and post-treatment samples, 5429 genes were found to be significantly associated. A total of 1115 genes are common in these two analyses. Additionally, nine significant genes from the first analysis and eight from the second are related to collagen. Six of these collagen genes are common in the two analyses. MAPK and cGMP-PKG signalling pathways are upregulated in the progression to photodamage analysis. In the pre- and post-treatment analysis, 32 pathways are downregulated after treatment, the most statistically significant being the ErbB, Hippo, NOD-like receptor, TNF, and NF-kB signalling pathways.

conclusionThis study demonstrates the role of SSNP in collagen generation, highlights the relevance of the cGMP-PKG and MAPK signalling pathways in photodamage, and shows the ability of SSNP to downregulate pathways activated by UV exposure. Additionally, it deepens our understanding of the effect of SSNP on immune-related pathways.

Indexed as

CollagenNicotinamidePhotodamage

Identifiers

PMID39509031
PMCPMC11604901

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.